Tech Company Financing Transactions
Terray Therapeutics Funding Round
Nventures, Alexandria Venture Investments and Digitalis Ventures participated in a $120 million Series B funding round for Terray Therapeutics. The round was announced by the company on 10/17/2024.
Transaction Overview
Company Name
Announced On
10/17/2024
Transaction Type
Venture Equity
Amount
$120,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to progress internal programs into clinical trials and further enhance its integrated AI platform, tNova, which it uses to power both internal and partnered programs.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
129 N Hill Ave. 103
Pasdena, CA 91106
USA
Pasdena, CA 91106
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
The first step to powering an engine is to add the right fuel. We're generating chemical data purpose-built for drug discovery in the information age. Our closed loop system generates precise chemical datasets at unrivaled scale that work seamlessly with AI to systematically map biochemical interactions between small molecules and causes of disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jacob Berlin
Chief Financial Officer
Eli Berlin
Browse more venture capital transactions:
Prev: 10/17/2024: dottxt venture capital transaction
Next: 10/17/2024: Cambri venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to document every notable VC transaction. VC investment data records reported here come from publicly available VC deal announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs